Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3-Reference-Cited by-同舟云学术

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

Published:2016-06-24 Issue:7 Volume:68 Page:1700-1710
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Fussner Lynn A.¹,Hummel Amber M.¹,Schroeder Darrell R.¹,Silva Francisco²,Cartin-Ceba Rodrigo¹,Snyder Melissa R.¹,Hoffman Gary S.³,Kallenberg Cees G. M.⁴,Langford Carol A.³,Merkel Peter A.⁵,Monach Paul A.⁶,Seo Philip⁷,Spiera Robert F.⁸,William St.Clair E.⁹,Tchao Nadia K.¹⁰,Stone John H.¹¹,Specks Ulrich¹,

Affiliation:

1. Mayo Clinic and Mayo Foundation for Medical Education and Research; Rochester Minnesota

2. Universidad del Desarrollo; Santiago Chile

3. Cleveland Clinic Foundation; Cleveland Ohio

4. University of Groningen; Groningen The Netherlands

5. University of Pennsylvania; Philadelphia

6. Boston University, Boston University Medical Center, and VA Boston Healthcare System; Boston Massachusetts

7. Johns Hopkins University; Baltimore Maryland

8. Hospital for Special Surgery; New York New York

9. Duke University Medical Center; Durham North Carolina

10. Immune Tolerance Network; San Francisco California

11. Massachusetts General Hospital; Boston Massachusetts